(A) qPCR demonstrating ENPP1 gene expression in the injured region of the heart compared with uninjured regions at 3, 7, 14, and 21 days after MI (n = 5). (B) Western blotting and quantitative densitometry demonstrating ENPP1 protein levels in injured and uninjured regions of the heart at 7 days following MI (n = 3). (C) ATP hydrolytic activity at various concentrations of the injured heart tissue homogenate compared with that in uninjured tissue homogenate 7 days after MI (n = 3). (D) Heatmap with gene expression patterns of ENPP1 (arrow) and other members of the ENPP and ectonucleotidase family in the injured versus uninjured regions of the heart (n = 4/time point). (E) ATP hydrolytic activity at 7 days after MI in WT mice and ENPP1asj/asj mutant mice (n = 3). (F and G) H&E staining and immunostaining for ENPP1 (green, arrowheads) in the uninjured (F) and injured (G) regions at day 7 after MI. Scale bar: 100 μm (high magnification). Low magnification: ×4. (H) Immunostaining for ENPP1 and vimentin in the uninjured and injured regions at 7 days after MI (arrowheads indicate ENPP1 and vimentin colocalization in merged images). (I and J) Immunostaining of ENNP1 expression in genetically labeled CFs in (I) Col1a2CreERT:R26Rtdtomato or (J) TCF21MCM:R26Rtdtomato mice at 7 days after MI (arrowheads indicate where ENPP1-expressing cells coexpress the fibroblast tdTomato label, representative images; n = 3). Scale bars: 10 μm. (K) Single-cell RNA-Seq of nonmyocytes at 7 days after MI demonstrating cell phenotypes in clusters and ENPP1 distribution (n = 3). Data are represented as mean ± SEM. **P < 0.01; *P < 0.05, 2-tailed Student’s t test (A–C and E).